Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

alembic pharmaceuticals inc. - febuxostat (unii: 101v0r1n2e) (febuxostat - unii:101v0r1n2e) - febuxostat tablets are xanthine oxidase (xo) inhibitor indicated for the chronic management of hyperuricemia in adult patients with gout who have an inadequate response to a maximally titrated dose of allopurinol, who are intolerant to allopurinol, or for whom treatment with allopurinol is not advisable. limitations of use : febuxostat tablets are not recommended for the treatment of asymptomatic hyperuricemia. febuxostat tablets are contraindicated in patients being treated with azathioprine or mercaptopurine [see drug interactions ( 7)] . risk summary   limited available data with febuxostat tablets use in pregnant women are insufficient to inform a drug associated risk of adverse developmental outcomes. no adverse developmental effects were observed in embryo-fetal development studies with oral administration of febuxostat to pregnant rats and rabbits during organogenesis at doses that produced maternal exposures up to 40 and 51 times, respectively, the exposure at the maximum recommended human dose (mrhd

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

northstar rxllc - febuxostat (unii: 101v0r1n2e) (febuxostat - unii:101v0r1n2e) - febuxostat tablets are xanthine oxidase (xo) inhibitor indicated for the chronic management of hyperuricemia in adult patients with gout who have an inadequate response to a maximally titrated dose of allopurinol, who are intolerant to allopurinol, or for whom treatment with allopurinol is not advisable. limitations of use : febuxostat tablets are not recommended for the treatment of asymptomatic hyperuricemia. febuxostat tablets are contraindicated in patients being treated with azathioprine or mercaptopurine [see drug interactions (7)] . risk summary limited available data with febuxostat use in pregnant women are insufficient to inform a drug associated risk of adverse developmental outcomes. no adverse developmental effects were observed in embryo-fetal development studies with oral administration of febuxostat to pregnant rats and rabbits during organogenesis at doses that produced maternal exposures up to 40 and 51 times, respectively, the exposure at the maximum recommended human dose (mrhd). no adver

Kenya - Tiếng Anh - Pharmacy and Poisons Board

febuxostat - film-coated tablet - febuxostat 40 mg - febuxostat

Kenya - Tiếng Anh - Pharmacy and Poisons Board

medisel kenya limited p.o box 540-01000 thika, kenya - febuxostat - tablet - febuxostat 40 mg - febuxostat

Kenya - Tiếng Anh - Pharmacy and Poisons Board

medisel kenya limited p.o box 540-01000 thika, kenya - febuxostat - tablet - febuxostat 80 mg - febuxostat

Kenya - Tiếng Anh - Pharmacy and Poisons Board

febuxostat - film-coated tablet - febuxostat 80mg - febuxostat

Liên Minh Châu Âu - Tiếng Anh - EMA (European Medicines Agency)

mylan pharmaceuticals limited - febuxostat - hyperuricemia; arthritis, gouty; gout - antigout preparations - febuxostat mylan is indicated for the prevention and treatment of hyperuricaemia in adult patients undergoing chemotherapy for haematologic malignancies at intermediate to high risk of tumor lysis syndrome (tls).febuxostat mylan is indicated for the treatment of chronic hyperuricaemia in conditions where urate deposition has already occurred (including a history, or presence of, tophus and/or gouty arthritis).febuxostat mylan is indicated in adults.

Malta - Tiếng Anh - Medicines Authority

pharos – pharmaceutical oriented services limited lesvou str. (end), thesi loggos, industrial zone, 144 52 metamorfossi attikis,, greece - febuxostat - film-coated tablet - febuxostat 80 mg - antigout preparations

Malta - Tiếng Anh - Medicines Authority

pharos – pharmaceutical oriented services limited lesvou str. (end), thesi loggos, industrial zone, 144 52 metamorfossi attikis,, greece - febuxostat - film-coated tablet - febuxostat 120 mg - antigout preparations

Liên Minh Châu Âu - Tiếng Anh - EMA (European Medicines Agency)

krka, d.d., novo mesto - febuxostat - hyperuricemia; gout - antigout preparations - febuxostat krka is indicated for the treatment of chronic hyperuricaemia in conditions where urate deposition has already occurred (including a history, or presence of, tophus and/or gouty arthritis).febuxostat krka is indicated in adults.